Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (menatetrenone)

Bone

Volumn 30, Issue 6, 2002, Pages 880-885

  Kokai, Y ^a   Wada, T ^a   Oda, T ^a   Kuwabara, H ^a   Hara, K ^b   Akiyama, Y ^b   Ishii, S ^a   Sawada, N ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Developing; Granulocyte colony stimulating factor (G CSF); Osteoporosis; Transgenic mice; Vitamin K2

Indexed keywords

COLONY STIMULATING FACTOR; MENATETRENONE; MK 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; BONE STRUCTURE; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DISEASE SEVERITY; FEEDING; GROWTH RETARDATION; MOUSE; NONHUMAN; OSTEOPENIA; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ULTRASTRUCTURE; VITAMIN SUPPLEMENTATION;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; GRANULOCYTE COLONY-STIMULATING FACTOR; MICE; MICE, TRANSGENIC; VITAMIN K 2;

EID: 0036276709     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00733-0     Document Type: Article

References (26)

1. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor
2. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women
3. Vitamin K intake and hip fractures in women: A prospective study
4. Granulocyte colony-stimulating factor (G-CSF): Preclinical and clinical studies
5. Osteoporosis in children and adolescent girls: Case report of idiopathic juvenile osteoporosis and review of the literature
6. Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of granulocyte-colony stimulating factor transgenic mice: Why they lost the ability of hybrid resistance
7. Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 trangenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow
8. Inhibition of resistance to hemopoietic allo-grafts in granulocyte colony-stimulating factor transgenic mice
9. Overexpression of the granulocyte colony-stimulating factor gene impairs bone morphogenic protein responsiveness in mice
10. Bone modulation in sustained hematopoietic stimulation in mice
11. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats
12. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood
13. Cell biology of the osteoclast
14. Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: Suggested therapeutic approach
15. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
16. Osteoporosis in severe congenital neutropenia: Inherent to the disease or a sequela of G-CSF treatment
17. The development of bone changes induced in rats by recombinant human granulocyte colony-stimulating factor is suppressed by bisphosphonate
18. Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice
19. The evolving role of bisphosphonates
20. The biology and clinical uses of blood stem cells
21. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy
22. A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: Preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor
23. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome)
24. Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF
25. Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia
26. Severe congenital neutropenia: Trends in diagnosis and therapy